Eleftheria Evdokia Kampouri

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


40 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2015 | 2012 |
 
Off-the-shelf allogeneic natural killer cells for the treatment of COVID-19.
Liu W.L., Kampouri E., Bui J.K., Sekhon M.K., Tercero A., Finlay D., Asghedom L.H., Romasanta G.R., Rice N.T., Ranjbaran F. et al., 2024/12/12. Molecular therapy. Methods & clinical development, 32 (4) p. 101361. Peer-reviewed.
 
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections.
Kampouri E., Reynolds G., Teh B.W., Hill J.A., 2024/12/01. Current opinion in infectious diseases, 37 (6) pp. 526-535. Peer-reviewed.
 
Striking the right balance: Navigating antimicrobial stewardship and antibiotic prescribing after CAR-T-cell therapy.
Reynolds G., Smibert O.C., Kampouri E., 2024/12. Transplant infectious disease, 26 (6) pp. e14395. Peer-reviewed.
 
Understanding the Clinical Significance of Cytomegalovirus Viremia After Chimeric Antigen Receptor T-Cell Therapy: Should We be Treating a Value?
Kampouri E., Boeckh M.J., Hill J.A., 2024/11/22. Clinical infectious diseases, 79 (5) pp. 1319-1320. Peer-reviewed.
 
Prevalence of HIV-related stigma among people with HIV in Switzerland: addressing the elephant in the room.
Kampouri E., Damas J., Kusejko K., Ledergerber B., Braun D., Nawej Tshikung O., Hachfeld A., Weisser M., Wissel K., Bernasconi E. et al., 2024/11/01. AIDS, 38 (13) pp. 1874-1884. Peer-reviewed.
 
CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation.
Zamora D., Xie H., Sadowska-Klasa A., Kampouri E., Biernacki M.A., Ueda Oshima M., Duke E., Green M.L., Kimball L.E., Holmberg L. et al., 2024/09/10. Blood advances, 8 (17) pp. 4568-4580. Peer-reviewed.
 
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients.
Kampouri E., Krantz E.M., Xie H., Ibrahimi S.S., Kiem E.S., Sekhon M.K., Liang E.C., Cowan A.J., Portuguese A., Green D.J. et al., 2024/08/01. Blood, 144 (5) pp. 490-495. Peer-reviewed.
 
Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications.
Kampouri E., Little J.S., Crocchiolo R., Hill J.A., 2024/08/01. Current opinion in infectious diseases, 37 (4) pp. 245-253. Peer-reviewed.
 
The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention.
Little J.S., Kampouri E., Friedman D.Z., McCarty T., Thompson G.R., Kontoyiannis D.P., Vazquez J., Baddley J.W., Hammond S.P., 2024/06. Open forum infectious diseases, 11 (6) pp. ofae133. Peer-reviewed.
 
Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy.
Kampouri E., Ibrahimi S.S., Xie H., Wong E.R., Hecht J.B., Sekhon M.K., Vo A., Stevens-Ayers T.L., Green D.J., Gauthier J. et al., 2024/04/10. Clinical infectious diseases, 78 (4) pp. 1022-1032. Peer-reviewed.
 
Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape.
Kampouri E., Handley G., Hill J.A., 2024/03/24. Viruses, 16 (4). Peer-reviewed.
 
COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy.
Kampouri E., Hill J.A., Dioverti V., 2023/11. Transplant infectious disease, 25 Suppl 1 pp. e14144. Peer-reviewed.
 
Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.
Kampouri E., Zamora D., Kiem E.S., Liu W., Ibrahimi S., Blazevic R.L., Lovas E.A., Kimball L.E., Huang M.L., Jerome K.R. et al., 2023/11. Clinical microbiology and infection, 29 (11) pp. 1450.e1-1450.e7. Peer-reviewed.
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
Kampouri E., Little J.S., Rejeski K., Manuel O., Hammond S.P., Hill J.A., 2023/11. Transplant infectious disease, 25 (Suppl 1) pp. e14157. Peer-reviewed.
 
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T., Choi Y., Pagani J.L., Kritikos A., Papadimitriou-Olivgeris M., Méan M., Scherz V., Opota O., Greub G., Guery B. et al., 2023/08/18. BMC infectious diseases, 23 (1) p. 537. Peer-reviewed.
 
Preemptive therapy versus universal prophylaxis: Time for reconciliation?
Kampouri E., Manuel O., 2023/04. Transplant infectious disease, 25 (2) pp. e14014. Peer-reviewed.
A first update on mapping the human genetic architecture of COVID-19
Pathak G. A., Polimanti R., Karjalainen J., Daly M., Ganna A., Daly M. J., Stevens C., Kanai M., Liao R. G., Trankiem A. et al., 2022/08. Nature, 608 (7921) pp. E1-E10. Peer-reviewed.
Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.
Kampouri E., Filippidis P., Wölfle M., Taveira A., Badinski T., Croxatto A., Galperine T., Grandbastien B., Achermann Y., Guery B., 2022/08. Infectious diseases now, 52 (5) pp. 267-272. Peer-reviewed.
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study.
Filippidis P., Kampouri E., Woelfle M., Badinski T., Croxatto A., Galperine T., Papadimitriou-Olivgeris M., Grandbastien B., Achermann Y., Guery B., 2022/06/30. Journal of clinical medicine, 11 (13) p. 3805. Peer-reviewed.
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Born T., Aruanno M., Kampouri E., Mombelli M., Monney P., Tozzi P., Lamoth F., 2022/06. Mycopathologia, 187 (2-3) pp. 249-258. Peer-reviewed.
 
Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E. et al., 2022/06. Journal of general internal medicine, 37 (8) pp. 1943-1952. Peer-reviewed.
 
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians.
Kampouri E., Walti C.S., Gauthier J., Hill J.A., 2022/04. Expert review of hematology, 15 (4) pp. 305-320. Peer-reviewed.
Mapping the human genetic architecture of COVID-19.
COVID-19 Host Genetics Initiative, Niemi M.E.K, 2021/12. Nature, 600 (7889) pp. 472-477. Peer-reviewed.
Épidémiologie et facteurs de risque des infections Covid nosocomiales dans le Service de médecine interne du CHUV [Epidemiology and risk factors of nosocomial COVID infections in the Service of internal medicine at CHUV]
Martin A., Kampouri E., Senn L., Sartori C., 2021/11/24. Revue medicale suisse, 17 (760) pp. 2049-2054. Peer-reviewed.
 
Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study.
Caruana G., Croxatto A., Kampouri E., Kritikos A., Opota O., Foerster M., Brouillet R., Senn L., Lienhard R., Egli A. et al., 2021/04/10. Microorganisms, 9 (4) p. 798. Peer-reviewed.
Clostridioides difficile Infection, Still a Long Way to Go.
Kampouri E., Croxatto A., Prod'hom G., Guery B., 2021/01/20. Journal of clinical medicine, 10 (3) pp. E389. Peer-reviewed.
COVID-19 Pandemics: A Surprising Link to Bread Flour With Collateral Damage to a Prosthetic Heart Valve.
Tozzi P., Kampouri E.E., Tzimas G., Prior J.O., Monney P., Kamani C., Lamoth F., 2020/10. Circulation. Cardiovascular imaging, 13 (10) pp. e011395. Peer-reviewed.
 
COVID-19 Pandemics: A Surprising Link to Bread Flour With Collateral Damage to a Prosthetic Heart Valve.
Tozzi P., Kampouri E.E., Tzimas G., Prior J.O., Monney P., Kamani C., Lamoth F., 2020/10. Circulation. Cardiovascular imaging, 13 (10) pp. e011395. Peer-reviewed.
 
Impact of universal infectious diseases consultation on the management of Staphylococcus aureus bloodstream infection in a Swiss community hospital.
Papadimitriou-Olivgeris M., Portillo V., Kampouri E.E., Nusbaumer C., Monnerat L.B., Duplain H., 2020/05. Diagnostic microbiology and infectious disease, 97 (1) p. 115001. Peer-reviewed.
Rubor, calor, dolor, tumor : infections de la peau et des tissus mous [Rubor, calor, dolor, tumor : skin and soft tissue infections]
Kampouri E., Filippidis P., Lhopitallier L., Pham T.T., Schuhler C., Toutous Trellu L., Mombelli M., Huttner B., 2020/04/15. Revue medicale suisse, 16 (690) pp. 732-738. Peer-reviewed.
Stigmatisation et VIH : tous concernés [Stigma and HIV: relevant for everyone]
Cobos Manuel I., Jackson-Perry D., Courvoisier C., Bluntschli C., Carel S., Muggli E., Waelti Da Costa V., Kampouri E., Cavassini M., Darling KEA, 2020/04/15. Revue medicale suisse, 16 (690) pp. 744-748. Peer-reviewed.
 
Predictors of mortality of influenza virus infections in a Swiss Hospital during four influenza seasons: Role of quick sequential organ failure assessment.
Papadimitriou-Olivgeris M., Gkikopoulos N., Wüst M., Ballif A., Simonin V., Maulini M., Nusbaumer C., Bertaiola Monnerat L., Tschopp J., Kampouri E.E. et al., 2020/04. European journal of internal medicine, 74 pp. 86-91. Peer-reviewed.
 
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.
Mombelli M., Kampouri E., Manuel O., 2020/02. Expert review of anti-infective therapy, 18 (2) pp. 103-112. Peer-reviewed.
VIH: prévention, traitement et perspectives [Novelties in HIV prevention and treatment in 2019]
Kampouri E., Papadimitriou-Olivgeris M., Calmy A., Ciuffi A., Cavassini M., 2020/01/15. Revue medicale suisse, 16 (676-7) pp. 92-98. Peer-reviewed.
 
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.
Regina J., Papadimitriou-Olivgeris M., Burger R., Le Pogam M.A., Niemi T., Filippidis P., Tschopp J., Desgranges F., Viala B., Kampouri E. et al., 2020. PloS one, 15 (11) pp. e0240781. Peer-reviewed.
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
Electrocardiographic Changes in Hypothermia.
Kampouri E., Vaucher J., 2018/02/01. The New England journal of medicine, 378 (5) p. 460. Peer-reviewed.
 
BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness.
Pelekanou V., Notas G., Athanasouli P., Alexakis K., Kiagiadaki F., Peroulis N., Kalyvianaki K., Kampouri E., Polioudaki H., Theodoropoulos P. et al., 2018. Frontiers in oncology, 8 p. 301. Peer-reviewed.
Accurate prediction of severe allergic reactions by a small set of environmental parameters (NDVI, temperature).
Notas G., Bariotakis M., Kalogrias V., Andrianaki M., Azariadis K., Kampouri E., Theodoropoulou K., Lavrentaki K., Kastrinakis S., Kampa M. et al., 2015. PloS one, 10 (3) pp. e0121475. Peer-reviewed.
 
Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx).
Kampa M., Notas G., Pelekanou V., Troullinaki M., Andrianaki M., Azariadis K., Kampouri E., Lavrentaki K., Castanas E., 2012/08. Steroids, 77 (10) pp. 959-967. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University